BlackRock Investment Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

BlackRock Investment Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-26	Closed	-$1K	–	4163
2016 Q1	$1K	Hold	26	–	–	﹤0.01%	4042
2015 Q4	$3K	Hold	26	–	–	﹤0.01%	3975
2015 Q3	$19K	Buy	26 +1	+4%	+$1.07K	﹤0.01%	3456
2015 Q2	$20K	Buy	25 +17	+213%	+$10.9K	﹤0.01%	3443
2015 Q1	$6K	Hold	8	–	–	﹤0.01%	3823
2014 Q4	$5K	Buy	+8	New	+$6.04K	﹤0.01%	3937

Other funds holding EVFM

CAD

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Investment Management's EVFM Position: Q2 2016 in Review

BlackRock Investment Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2016, closing a stake of 26 shares — an estimated $1K sold.

BlackRock Investment Management first reported a position in EVFM in Q4 2014 and held it in 6 quarters. The position peaked at $20K in Q2 2015. 17 funds tracked by Wall St. Rank hold EVFM as of Q2 2016.

BlackRock Investment Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 26 Evofem Biosciences, Inc. Common Stock shares in Q2 2016, an estimated $1K.
BlackRock Investment Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 6 quarters.
BlackRock Investment Management's Evofem Biosciences, Inc. Common Stock position peaked at $20K in Q2 2015.
17 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.